| Dr Alan Joseph Rodney, MD | |
|
501 Medical Center Blvd, Webster, TX 77598 | |
| (281) 332-7505 | |
| (281) 332-7616 |
| Full Name | Dr Alan Joseph Rodney |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 24 Years |
| Location | 501 Medical Center Blvd, Webster, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881615243 | NPI | - | NPPES |
| 163377805 | Medicaid | TX | |
| 8W0436 | Other | TX | BLUECROSS BLUESHIELD |
| 163377804 | Medicaid | TX | |
| 163377806 | Medicaid | TX | |
| 163377807 | Medicaid | TX | |
| 163377808 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | L6603 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Hca Houston Healthcare Clear Lake | Webster, TX | Hospital |
| University Of Texas Medical Branch Galveston | Galveston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oncology Pa | 5395658934 | 855 |
News Archive
Living with HIV is difficult under the best of circumstances, but for people carrying the virus, alcohol consumption can become particularly perilous in intricate ways that are only beginning to be understood. At the Brown Alcohol Research Center on HIV (ARCH) funded by a new $7.5-million, five-year grant from the National Institutes of Health, Brown University scientists will study the health effects of drinking with HIV and provide doctors and patients with the latest guidance their results suggest.
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
Scientists have zeroed in on a structural protein as a new target for the diagnosis and treatment of depression, according to research recently published in JNeurosci.
About one in three American adults experienced a symptom consistent with a warning or "mini" stroke, but almost none - 3 percent - took the recommended action, according to a new survey from the American Heart Association/American Stroke Association.
Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").
› Verified 9 days ago
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
Living with HIV is difficult under the best of circumstances, but for people carrying the virus, alcohol consumption can become particularly perilous in intricate ways that are only beginning to be understood. At the Brown Alcohol Research Center on HIV (ARCH) funded by a new $7.5-million, five-year grant from the National Institutes of Health, Brown University scientists will study the health effects of drinking with HIV and provide doctors and patients with the latest guidance their results suggest.
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
Scientists have zeroed in on a structural protein as a new target for the diagnosis and treatment of depression, according to research recently published in JNeurosci.
About one in three American adults experienced a symptom consistent with a warning or "mini" stroke, but almost none - 3 percent - took the recommended action, according to a new survey from the American Heart Association/American Stroke Association.
Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan Joseph Rodney, MD Po Box 911230, Dallas, TX 75391-1230 Ph: (972) 997-8000 | Dr Alan Joseph Rodney, MD 501 Medical Center Blvd, Webster, TX 77598 Ph: (281) 332-7505 |
News Archive
Living with HIV is difficult under the best of circumstances, but for people carrying the virus, alcohol consumption can become particularly perilous in intricate ways that are only beginning to be understood. At the Brown Alcohol Research Center on HIV (ARCH) funded by a new $7.5-million, five-year grant from the National Institutes of Health, Brown University scientists will study the health effects of drinking with HIV and provide doctors and patients with the latest guidance their results suggest.
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
Scientists have zeroed in on a structural protein as a new target for the diagnosis and treatment of depression, according to research recently published in JNeurosci.
About one in three American adults experienced a symptom consistent with a warning or "mini" stroke, but almost none - 3 percent - took the recommended action, according to a new survey from the American Heart Association/American Stroke Association.
Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").
› Verified 9 days ago
Dr. Atul Matta, M.B.B.S Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 200 Blossom St, Webster, TX 77598 Phone: 832-632-6500 | |
Niraj Choudhary, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 360 E Medical Center Blvd, Suite A, Webster, TX 77598 Phone: 832-932-5669 Fax: 832-932-5249 | |
Maha Khalifa Al-lahiq, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 N Kobayashi, Suite A, Webster, TX 77598 Phone: 281-724-1860 Fax: 281-724-1861 | |
Halie Shah, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 19419 Gulf Fwy, Webster, TX 77598 Phone: 281-316-1000 Fax: 281-316-0112 | |
Dr. Alfred Salim Maksoud, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 501 Orchard St, Suite 200, Webster, TX 77598 Phone: 281-557-8555 | |
Dr. Snehalkumar Arjunbhai Patel, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 201 Blossom St, Suite C, Webster, TX 77598 Phone: 832-376-8500 Fax: 832-376-8505 | |
Souad Enakuaa, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 600 N Kobayashi Ste 312, Webster, TX 77598 Phone: 281-724-8333 Fax: 281-336-1680 |